X0708 D LIVE 0001815903 Petros Pharmaceuticals, Inc. 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY NEW YORK 10036 973-242-0005 DELAWARE None None Corporation true 2020 Mitchell Arnold 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Executive Officer Vice President of Finance and Principal Accounting Officer Fady Boctor 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Executive Officer President and Chief Commercial Officer John D. Shulman 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Director Joshua N. Silverman 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Director Bruce T. Bernstein 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Director Gregory Bradley 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Director Wayne R. Walker 1185 Avenue of the Americas 3rd Floor New York NY NEW YORK 10036 Director Pharmaceuticals Decline to Disclose 06b false 2023-07-13 false true true true false 0 Katalyst Securities LLC 112494 None None 655 THIRD AVENUE, 18TH FLOOR NEW YORK NY NEW YORK 10017 CT CONNECTICUT FL FLORIDA NJ NEW JERSEY NY NEW YORK false 30000006 30000006 0 Includes aggregate exercise price of warrants of $2.25 (subject to price-based adjustment), that may be received upon exercise of the warrants false 15 1200000 0 Issuer issued to placement agent (and its designees) warrants to purchase up to 533,334 shares at an exercise price of $2.25 (subject to price-based adjustment) under Section 4(a)(2) 0 false Petros Pharmaceuticals, Inc. /s/ Fady Boctor Fady Boctor President and Chief Commercial Officer 2023-07-21